These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1709701)

  • 1. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4.
    Kost TA; Kessler JA; Patel IR; Gray JG; Overton LK; Carter SG
    J Virol; 1991 Jun; 65(6):3276-83. PubMed ID: 1709701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
    Vincent MJ; Raja NU; Jabbar MA
    J Virol; 1993 Sep; 67(9):5538-49. PubMed ID: 8350411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type-1 envelope glycoprotein gp120 induces expression of fusion regulatory protein (FRP)-1/CD98 on CD4+ T cells: a possible regulatory mechanism of HIV-induced syncytium formation.
    Suga S; Tsurudome M; Ito M; Ohgimoto S; Tabata N; Nishio M; Kawano M; Komada H; Ito M; Sakurai M; Ito Y
    Med Microbiol Immunol; 1997 Mar; 185(4):237-43. PubMed ID: 9138296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.
    Weiss CD; White JM
    J Virol; 1993 Dec; 67(12):7060-6. PubMed ID: 8230430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins.
    Salzwedel K; Johnston PB; Roberts SJ; Dubay JW; Hunter E
    J Virol; 1993 Sep; 67(9):5279-88. PubMed ID: 8102410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    Grimaila RJ; Fuller BA; Rennert PD; Nelson MB; Hammarskjöld ML; Potts B; Murray M; Putney SD; Gray G
    J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of p56lck, a lymphocyte specific protein tyrosine kinase, on the syncytium formation induced by human immunodeficiency virus envelope glycoprotein.
    Yoshida H; Koga Y; Moroi Y; Kimura G; Nomoto K
    Int Immunol; 1992 Feb; 4(2):233-42. PubMed ID: 1622897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
    Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
    J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
    Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
    J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syncytium induction by fresh HIV isolates: quantitative analysis using a transactivation beta-gal assay.
    Emilie D; Maillot MC; Bonnerot C; Devergne O; Delfraissy JF; Nicolas JF; Galanaud P
    AIDS; 1990 Aug; 4(8):791-7. PubMed ID: 1979746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
    Broder CC; Berger EA
    J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
    Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
    J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
    Bergelson JM; Chan M; Solomon KR; St John NF; Lin H; Finberg RW
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6245-8. PubMed ID: 7517044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface plasmon resonance analysis of gp17, a natural CD4 ligand from human seminal plasma inhibiting human immunodeficiency virus type-1 gp120-mediated syncytium formation.
    Autiero M; Gaubin M; Mani JC; Castejon C; Martin M; el Marhomy S; Guardiola J; Piatier-Tonneau D
    Eur J Biochem; 1997 Apr; 245(1):208-13. PubMed ID: 9128743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.
    Jabbar MA; Nayak DP
    J Virol; 1990 Dec; 64(12):6297-304. PubMed ID: 2243395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene.
    Schröder HC; Ugarkovic D; Merz H; Kuchino Y; Okamoto T; Müller WE
    FASEB J; 1990 Oct; 4(13):3124-30. PubMed ID: 1698680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells.
    Heinkelein M; Sopper S; Jassoy C
    J Virol; 1995 Nov; 69(11):6925-31. PubMed ID: 7474110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.